Category: Health Alert Network

Central District Health (CDH) has confirmed that exposure to TB may have occurred at Centennial High School in Boise between May and October 2022. There is no ongoing risk and people are safe to attend school and school events as usual.

On October 22, 2022 RSV season onset was declared in Idaho and activity continues increasing rapidly. Pediatric hospital inpatient bed capacity is limited and could continue to be strained throughout the respiratory disease season. The United States is currently experiencing high levels of respiratory virus activity, especially among children, across multiple jurisdictions.

On September 20, 2022, the Ministry of Health of Uganda officially declared an outbreak of Ebola virus disease (EVD) due to Sudan virus (species Sudan ebolavirus) in Mubende District, Central Uganda.

As of August 25, 2022, ten cases of monkeypox have been reported in Idaho and community transmission has been identified. Idaho case counts can be found at Department of Health and Welfare. Please see below for updated recommendations and resources.

Clinicians should be aware that in the current monkeypox outbreak in the U.S, clinical cases may not be recognized and tested because of uncharacteristic features compared to historical outbreaks and cases. No cases have been identified to date in Idaho.

The Massachusetts Department of Public Health and the Centers for Disease Control and Prevention confirmed a case of monkeypox in the United States infected with a West African strain of the virus...Idaho public health officials are asking clinicians to be vigilant to the characteristic rash associated with monkeypox.

The Centers for Disease Control and Prevention (CDC) and Idaho public health agencies are issuing this Health Alert Network (HAN) Health Advisory to notify clinicians and public health authorities of a cluster of children identified with hepatitis and adenovirus infection in Alabama; no cases have been reported in Idaho to date.

Death cap mushrooms (Amanita phalloides) were recently identified for the first time in Idaho. The mushroom was found in Boise but may be present and undetected in other areas. The mushroom may be confused with edible mushrooms.

Updates include: Evusheld (tixagevimab co-packaged with cilgavimab) is expected to be effective against Omicron, including the BA.2 subvariant; Sotrovimab is no longer authorized for use in Idaho; Oral antivirals are available throughout Idaho.

Central District Health continues to respond to a rise in syphilis infections in our communities. In the past six months, between Public Health Districts 3 and 4, more than 60 early syphilis infections (primary, secondary, and early latent) have been identified. This represents a significant increase compared to 32 infections during the same timeframe two years ago.